Andreas E Kremer
5PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 24, 2025
Long-Term Efficacy and Safety of Selective PPARδ Agonist Seladelpar in Primary Biliary Cholangitis: ASSURE Interim Study Results.Cynthia Levy, Palak J Trivedi, Kris V Kowdley
|Mar 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder
|Dec 20, 2023
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis.Andreas E Kremer, Marlyn J Mayo, Gideon M Hirschfield
|Jun 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein
|Jun 24, 2021
Lysophosphatidic acid activates nociceptors and causes pain or itch depending on the application mode in human skin.Miriam M Düll, Martina Stengel, Vivien Ries
Pageof 1
Frequent Collaborators
4 joint publications
Marlyn Mayo
4 joint publications
Cynthia Levy
3 joint publications
Gideon M Hirschfield
3 joint publications
Charles A McWherter
3 joint publications
Palak Trivedi
3 joint publications
Christopher L Bowlus
2 joint publications
Christophe Corpechot
2 joint publications
Kris V Kowdley
2 joint publications
John M Vierling
2 joint publications
Eric J Lawitz
